Anterix (ATEX) Current Deferred Revenue (2016 - 2025)

Anterix filings provide 12 years of Current Deferred Revenue readings, the most recent being $7.9 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue fell 93.76% to $7.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.9 million, a 93.76% decrease, with the full-year FY2025 number at $6.1 million, down 95.01% from a year prior.
  • Current Deferred Revenue hit $7.9 million in Q4 2025 for Anterix, down from $130.4 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $130.4 million in Q3 2025 to a low of $737000.0 in Q2 2021.
  • Median Current Deferred Revenue over the past 5 years was $54.3 million (2022), compared with a mean of $55.1 million.
  • Biggest five-year swings in Current Deferred Revenue: surged 7219.54% in 2022 and later crashed 95.01% in 2025.
  • Anterix's Current Deferred Revenue stood at $1.5 million in 2021, then surged by 441.27% to $8.0 million in 2022, then dropped by 13.75% to $6.9 million in 2023, then soared by 1726.97% to $126.1 million in 2024, then tumbled by 93.76% to $7.9 million in 2025.
  • The last three reported values for Current Deferred Revenue were $7.9 million (Q4 2025), $130.4 million (Q3 2025), and $128.2 million (Q2 2025) per Business Quant data.